Building research capacity through programme development and research implementation in resource-limited settings - the Ipabalele study protocol: observational cohort studies determining the effect of HIV on the natural history of cervical cancer in Botswana.


Journal

BMJ open
ISSN: 2044-6055
Titre abrégé: BMJ Open
Pays: England
ID NLM: 101552874

Informations de publication

Date de publication:
30 12 2019
Historique:
entrez: 2 1 2020
pubmed: 2 1 2020
medline: 15 12 2020
Statut: epublish

Résumé

The global burden of cancer continues to increase in low- and middle-income countries, particularly in sub-Saharan Africa (SSA). Botswana, a middle-income country in SSA, has the second highest prevalence of HIV worldwide and has seen an increase in human papillomavirus (HPV)-associated cervical cancer over the last decade in the setting of improved survival of HIV-infected women. There is an urgent need to understand more clearly the causes and consequences of HPV-associated cervical cancer in the setting of HIV infection. We initiated the Ipabalele ('take care of yourself' in Setswana) programme to address this need for new knowledge and to initiate long-term research programme capacity building in the region. In this manuscript, we describe the components of the programme, including three main research projects as well as a number of essential cores to support the activities of the programme. Our multidisciplinary approach aims to further current understanding of the problem by implementing three complementary studies aimed at identifying its molecular, behavioural and clinical determinants. Three participant cohorts were designed to represent the early, intermediate and late stages of the natural history of cervical cancer.The functional structure of the programme is coordinated through programmatic cores. These allow for integration of each of the studies within the cohorts while providing support for pilot studies led by local junior investigators. Each project of the Ipabalele programme includes a built-in capacity building component, promoting the establishment of long-lasting infrastructure for future research activities. Institutional review board approvals were granted by the University of Pennsylvania, University of Botswana and Ministry of Health and wellness of Botswana. Results will be disseminated via the participating institutions and with the help of the Community Advisory Committee, the project's Botswana advisory group.

Identifiants

pubmed: 31892649
pii: bmjopen-2019-031103
doi: 10.1136/bmjopen-2019-031103
pmc: PMC6955487
doi:

Types de publication

Journal Article Research Support, N.I.H., Extramural

Langues

eng

Sous-ensembles de citation

IM

Pagination

e031103

Subventions

Organisme : NCI NIH HHS
ID : K08 CA230170
Pays : United States
Organisme : NCI NIH HHS
ID : U54 CA190158
Pays : United States

Informations de copyright

© Author(s) (or their employer(s)) 2019. Re-use permitted under CC BY-NC. No commercial re-use. See rights and permissions. Published by BMJ.

Déclaration de conflit d'intérêts

Competing interests: None declared.

Références

Int J Cancer. 2015 Mar 1;136(5):E359-86
pubmed: 25220842
Open AIDS J. 2014 Dec 19;8:58-65
pubmed: 25624955
Gynecol Oncol Rep. 2016 Nov 25;19:5-9
pubmed: 28004030
PLoS One. 2015 Aug 12;10(8):e0135602
pubmed: 26267867
J Infect Dis. 2009 Jun 15;199(12):1851-61
pubmed: 19435429
Int J Radiat Oncol Biol Phys. 2018 May 1;101(1):201-210
pubmed: 29619965
Br J Cancer. 2015 Sep 15;113(6):861-3
pubmed: 26313666
Int J Gynecol Cancer. 2006 Jul-Aug;16(4):1614-9
pubmed: 16884375
Int J Gynaecol Obstet. 2009 May;105(2):103-4
pubmed: 19367689
J Natl Cancer Inst. 1995 Jun 7;87(11):796-802
pubmed: 7791229
J Clin Oncol. 2004 Mar 1;22(5):872-80
pubmed: 14990643

Auteurs

Surbhi Grover (S)

Department of Radiation Oncology, University of Pennsylvania Perelman School of Medicine, Philadelphia, Pennsylvania, USA Surbhi.Grover@pennmedicine.upenn.edu.
Botswana-UPenn Partnership, Gaborone, Botswana.

Nicola Zetola (N)

Department of Radiation Oncology, University of Pennsylvania Perelman School of Medicine, Philadelphia, Pennsylvania, USA.

Doreen Ramogola-Masire (D)

Department of Obstetrics & Gynecology, Botswana-UPenn Partnership, Gaborone, Botswana.

Memory Bvochora-Nsingo (M)

Life Gaborone Private Hospital, Gaborone, Gaborone, Botswana.

Allison F Schnader (AF)

Department of Radiation Oncology, University of Pennsylvania Perelman School of Medicine, Philadelphia, Pennsylvania, USA.
Marian University College of Osteopathic Medicine, Indianapolis, Indiana, USA.

Rosemarie Mick (R)

Department of Biostatistics, Epidemiology, and Informatics, University of Pennsylvania Perelman School of Medicine, Philadelphia, Pennsylvania, USA.

Lesego Gabaitiri (L)

Department of Statistics, University of Botswana, Gaborone, Gaborone, Botswana.

Keikantse Matlhagela (K)

Department of Biomedical Sciences, Faculty of Medicine, University of Botswana, Gaborone, Gaborone, Botswana.

Hao Shen (H)

Department of Microbiology, University of Pennsylvania Perelman School of Medicine, Philadelphia, Pennsylvania, USA.

Sebathu Chiyapo (S)

Life Gaborone Private Hospital, Gaborone, Gaborone, Botswana.

Dawn Balang (D)

Life Gaborone Private Hospital, Gaborone, Gaborone, Botswana.

Nthabiseng Phaladze (N)

School of Nursing, University of Botswana, Gaborone, Botswana.

Oathokwa Nkomazana (O)

Department of Surgery, Faculty of Medicine, University of Botswana, Gaborone, Gaborone, Botswana.

Harvey Friedman (H)

Botswana-UPenn Partnership, Gaborone, Botswana.
Department of Medicine, University of Pennsylvania Perelman School of Medicine, Philadelphia, Pennsylvania, USA.

John Jemmott (J)

Annenberg School for Communication, University of Pennsylvania, Philadelphia, Pennsylvania, USA.

Bagele Chilisa (B)

University of Botswana, Gaborone, Gaborone, Botswana.

Erle S Robertson (ES)

Department of Otorhinolaryngology-Head and Neck Surgery, University of Pennsylvania Perelman School of Medicine, Philadelphia, Pennsylvania, USA.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH